Lombard Odier & Cie (Bahamas)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q4
Sell
-3,500
Closed -$580K 93
2014
Q3
$580K Hold
3,500
0.21% 50
2014
Q2
$547K Hold
3,500
0.2% 48
2014
Q1
$532K Hold
3,500
0.21% 46
2013
Q4
$466K Buy
+3,500
New +$466K 0.18% 55